Selected Publications
Nguyen P, Okeke E, Clay M, Haydar D, Justice J, O’Reilly C, Pruett-Miller S, Papizan J, Moore J, Zhou S, Throm R, Krenciute G, Gottschalk S, and DeRenzo C. Route of 41BB/41BBL costimulation determines effector function of B7-H3-CAR.CD28ζ T cells. Molecular Therapy–Oncoloytics 18:202-214, 2020.
Hegde M, Pashankar F, Joseph S, DeRenzo C, Sanber K, Byrd T, Hicks J, Xu M, Gerken C, Kalra M, Robertson C, Zhang H, Shree A, Dakhova O, Salsman V, Grilley B, Gee A, Dotti G, Heslop H, Brenner M, Wels W, Gottschalk S, Ahmed N. HER2-specific CAR T cells induce Complete Remission of Bone Marrow Metastatic Rhabdomyosarcoma. Nature Communications 2020.
Cao F, Nguyen P, Hong B, DeRenzo C, Rainusso N, Rodriguez-Cruz T, Wu M, Liu H, Song X, Suzuki M, Wang L, Yustein J, Gottschalk S. Engineering oncolytic vaccinia virus to redirect macrophages to tumor cells. Advances in Cell and Gene Therapy 2020.
DeRenzo C, Gottschalk S. Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s. Current Advances in Osteosarcoma. Advances in Experimental Medicine and Biology 1257:109-131, 2020.
DeRenzo C, Gottschalk S. Genetic modification strategies to enhance CAR T cell persistence for patients with solid tumors. Frontiers in Immunology 10:218, 2019.
DeRenzo C, Lam C, Rodriguez‐Galindo C, Rapkin L, Gottschalk S, Venkatramani R. Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma. Pediatric Blood & Cancer 66(1):e27469, 2019.
Last update: August 2020